Despite challenges, the emergence of new drugs like Leqembi signifies a turning point in the fight against Alzheimer’s. Research is accelerating, and the scientific community is no longer solely focused on managing symptoms but also on modifying the disease course.
Now Accepting MetLife Legal Plan Participants